Evidence map›Paper›PMID 30872748›Full record

ArticleScientific reports2019

Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East.

Essam J Alyamani, Sarah A Marcus, Sarah M Ramirez-Busby, Chungyi Hansen, Julien Rashid, Amani El-Kholy, Daniel Spalink, Faramarz Valafar, Hussein A Almehdar, Asif A Jiman-Fatani and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. A Saudi Arabian Public Health Perspective of Tuberculosis.International journal of environmental research and public health · 2021
    Review
  8. Low-Level Rifampin Resistance andJournal of clinical microbiology · 2021
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Essam J AlyamaniNational Center for Biotechnology, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.
Sarah A MarcusDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-3795-0806
Sarah M Ramirez-BusbyLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, Biomedical Informatics Research Center, San Diego State University, San Diego, CA, USA.
Chungyi HansenDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Julien RashidDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Amani El-KholyClinical Pathology Department, Faculty of Medicine Cairo University, Cairo, Egypt.
Daniel SpalinkDepartment of Ecosystem Science and Management, Texas A&M University, College Station, TX, USA.
Faramarz ValafarLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, Biomedical Informatics Research Center, San Diego State University, San Diego, CA, USA.
Hussein A AlmehdarDepartment of Biology, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Asif A Jiman-FataniDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohamed A KhiyamiNational Center for Biotechnology, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.
Adel M TalaatDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA. Adel.Talaat@wisc.edu.

Funding

Immunogenicity of A Novel Live Attenuated Tuberculosis VaccineR21AI141090 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI TALAAT, ADEL M · 2018 to 2019
$400k
NIAID NIH HHS R21 AI141090
6 · The paper itself

Abstract

Tuberculosis (TB) represents a significant challenge to public health authorities, especially with the emergence of drug-resistant (DR) and multidrug-resistant (MDR) isolates of Mycobacterium tuberculosis. We sought to examine the genomic variations among recently isolated strains of M. tuberculosis in two closely related countries with different population demography in the Middle East. Clinical isolates of M. tuberculosis from both Egypt and Saudi Arabia were subjected to phenotypic and genotypic analysis on gene and genome-wide levels. Isolates with MDR phenotypes were highly prevalent in Egypt (up to 35%) despite its relatively stable population structure (sympatric pattern). MDR-TB isolates were not identified in the isolates from Saudi Arabia despite its active guest worker program (allopatric pattern). However, tuberculosis isolates from Saudi Arabia, where lineage 4 was more prevalent (>65%), showed more diversity than isolates from Egypt, where lineage 3 was the most prevalent (>75%). Phylogenetic and molecular dating analyses indicated that lineages from Egypt were recently diverged (~78 years), whereas those from Saudi Arabia were diverged by over 200 years. Interestingly, DR isolates did not appear to cluster together or spread more widely than drug-sensitive isolates, suggesting poor treatment as the main cause for emergence of drug resistance rather than more virulence or more capacity to persist.

Indexed as

Drug Resistance, BacterialAdolescentAdultAgedChildChild, PreschoolEgyptFemaleHumansInfantMaleMiddle AgedMycobacterium tuberculosisPhylogenyPrevalenceSaudi Arabia

Identifiers

PMID30872748
PMCPMC6418154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.